These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21628707)

  • 41. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].
    Jia YB; Wang Y; Ling XY; Zhong SM; Huang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal 4.0 Tesla (31)P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia.
    Miller J; Williamson P; Jensen JE; Manchanda R; Menon R; Neufeld R; Rajakumar N; Pavlosky W; Densmore M; Schaefer B; Drost DJ
    Psychiatry Res; 2009 Aug; 173(2):155-7. PubMed ID: 19520552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.
    Ota M; Ishikawa M; Sato N; Hori H; Sasayama D; Hattori K; Teraishi T; Nakata Y; Kunugi H
    Acta Psychiatr Scand; 2012 Jul; 126(1):72-8. PubMed ID: 22432602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Grey matter abnormalities in first-episode schizophrenia and affective psychosis.
    Morgan KD; Dazzan P; Orr KG; Hutchinson G; Chitnis X; Suckling J; Lythgoe D; Pollock SJ; Rossell S; Shapleske J; Fearon P; Morgan C; David A; McGuire PK; Jones PB; Leff J; Murray RM
    Br J Psychiatry Suppl; 2007 Dec; 51():s111-6. PubMed ID: 18055926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.
    Mechtcheriakov S; Schocke M; Kugener A; Graziadei IW; Mattedi M; Hinterhuber H; Vogel W; Marksteiner J
    Neuroradiology; 2005 Jan; 47(1):27-34. PubMed ID: 15655660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.
    Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF
    Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
    Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Neurosci Lett; 2015 Oct; 606():7-12. PubMed ID: 26306650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of age and sex on the concentrations of glutamate and glutamine in the human brain.
    Hädel S; Wirth C; Rapp M; Gallinat J; Schubert F
    J Magn Reson Imaging; 2013 Dec; 38(6):1480-7. PubMed ID: 23564615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
    Ohrmann P; Kugel H; Bauer J; Siegmund A; Kölkebeck K; Suslow T; Wiedl KH; Rothermundt M; Arolt V; Pedersen A
    Schizophr Res; 2008 Dec; 106(2-3):156-63. PubMed ID: 18799290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials.
    Stone JM; Bramon E; Pauls A; Sumich A; McGuire PK
    Psychiatry Res; 2010 Aug; 183(2):174-6. PubMed ID: 20620033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia.
    Tibbo P; Hanstock C; Valiakalayil A; Allen P
    Am J Psychiatry; 2004 Jun; 161(6):1116-8. PubMed ID: 15169703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased thalamus levels of glutamate and glutamine (Glx) in patients with idiopathic generalised epilepsy.
    Helms G; Ciumas C; Kyaga S; Savic I
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):489-94. PubMed ID: 16543528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
    Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
    Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal white matter connections between medial frontal regions predict symptoms in patients with first episode schizophrenia.
    Ohtani T; Bouix S; Lyall AE; Hosokawa T; Saito Y; Melonakos E; Westin CF; Seidman LJ; Goldstein J; Mesholam-Gately R; Petryshen T; Wojcik J; Kubicki M
    Cortex; 2015 Oct; 71():264-76. PubMed ID: 26277547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
    Rogdaki M; Hathway P; Gudbrandsen M; McCutcheon RA; Jauhar S; Daly E; Howes O
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1333-1342. PubMed ID: 31648854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.